Current and Emerging Technology for Continuous Glucose Monitoring
Clicks: 155
ID: 116014
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
154 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Diabetes has become a leading cause of death worldwide. Although there is no cure for diabetes, blood glucose monitoring combined with appropriate medication can enhance treatment efficiency, alleviate the symptoms, as well as diminish the complications. For point-of-care purposes, continuous glucose monitoring (CGM) devices are considered to be the best candidates for diabetes therapy. This review focuses on current growth areas of CGM technologies, specifically focusing on subcutaneous implantable electrochemical glucose sensors. The superiority of CGM systems is introduced firstly, and then the strategies for fabrication of minimally-invasive and non-invasive CGM biosensors are discussed, respectively. Finally, we briefly outline the current status and future perspective for CGM systems.
| Reference Key |
chen2017sensorscurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Cheng Chen;Xue-Ling Zhao;Zhan-Hong Li;Zhi-Gang Zhu;Shao-Hong Qian;Andrew J. Flewitt;Chen, Cheng;Zhao, Xue-Ling;Li, Zhan-Hong;Zhu, Zhi-Gang;Qian, Shao-Hong;Flewitt, Andrew J.; |
| Journal | sensors |
| Year | 2017 |
| DOI |
10.3390/s17010182
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.